299 related articles for article (PubMed ID: 25632186)
1. Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival.
Zhao Z; Han FH; Yang SB; Hua LX; Wu JH; Zhan WH
World J Gastroenterol; 2015 Jan; 21(4):1140-7. PubMed ID: 25632186
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
3. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.
Bae JM; Lee TH; Cho NY; Kim TY; Kang GH
World J Gastroenterol; 2015 Feb; 21(5):1457-67. PubMed ID: 25663765
[TBL] [Abstract][Full Text] [Related]
4. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856
[TBL] [Abstract][Full Text] [Related]
5. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT
J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
7. ARID1A expression in early stage colorectal adenocarcinoma: an exploration of its prognostic significance.
Lee LH; Sadot E; Ivelja S; Vakiani E; Hechtman JF; Sevinsky CJ; Klimstra DS; Ginty F; Shia J
Hum Pathol; 2016 Jul; 53():97-104. PubMed ID: 26980037
[TBL] [Abstract][Full Text] [Related]
8. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
9. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
[TBL] [Abstract][Full Text] [Related]
10. Desmoplastic Pattern at the Tumor Front Defines Poor-prognosis Subtypes of Colorectal Cancer.
Ueno H; Kanemitsu Y; Sekine S; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Mochizuki S; Kajiwara Y; Shinto E; Yamamoto J
Am J Surg Pathol; 2017 Nov; 41(11):1506-1512. PubMed ID: 28877064
[TBL] [Abstract][Full Text] [Related]
11. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
12. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
Singhi AD; Foxwell TJ; Nason K; Cressman KL; McGrath KM; Sun W; Bahary N; Zeh HJ; Levy RM; Luketich JD; Davison JM
Am J Surg Pathol; 2015 Apr; 39(4):487-95. PubMed ID: 25634752
[TBL] [Abstract][Full Text] [Related]
13. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
[TBL] [Abstract][Full Text] [Related]
14. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer.
Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M
Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497
[TBL] [Abstract][Full Text] [Related]
15. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of adhesion molecule expression in colorectal cancer.
Seo KJ; Kim M; Kim J
Int J Clin Exp Pathol; 2015; 8(4):4148-57. PubMed ID: 26097606
[TBL] [Abstract][Full Text] [Related]
17. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers.
Witkiewicz AK; Dasgupta A; Sotgia F; Mercier I; Pestell RG; Sabel M; Kleer CG; Brody JR; Lisanti MP
Am J Pathol; 2009 Jun; 174(6):2023-34. PubMed ID: 19411448
[TBL] [Abstract][Full Text] [Related]
18. Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.
Ahadi M; Andrici J; Sioson L; Sheen A; Clarkson A; Gill AJ
Hum Pathol; 2016 Nov; 57():91-97. PubMed ID: 27476040
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
Tang K; Wang C; Chen Z; Xu H; Ye Z
Int J Clin Exp Pathol; 2015; 8(5):4999-5007. PubMed ID: 26191193
[TBL] [Abstract][Full Text] [Related]
20. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
